Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Acorn Bioventures
New York City, New York, United Statesacornbioventures.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Acorn Bioventures is a New York-based venture capital and private equity firm investing across all stages in small-cap public and private biotechnology, specialty pharmaceutical, and medical device companies focused on bringing novel innovative medicines to patients. Their investments have included numerous successful IPOs and acquisitions within the life sciences sector.
- Modalities
- Small molecule (via portfolio)Monoclonal antibody (via portfolio)Biologic (via portfolio)
- Industry
- Investors
02
Partnerships
Atlas VenturePolaris PartnersAisling CapitalFlagship VenturesU.S. Venture Partners (USVP)OrbiMedAberdare VenturesSofinnova Investments
Beyond the preview
Go deeper on Acorn Bioventures.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Acorn Bioventures.